Function
Locations
Bifunctional; converts L-lysine to 2-aminoadipate semialdehyde via saccharopine.
The saccharopine pathway is the main route of L-lysine degradation in mammals, converting lysine to acetyl-CoA through 2-aminoadipate and glutaryl-CoA, predominantly in liver and brain mitochondria. The bifunctional enzyme AASS (2-aminoadipic-6-semialdehyde synthase) catalyses the first two steps: its lysine-ketoglutarate reductase domain condenses L-lysine with 2-oxoglutarate to saccharopine, and its saccharopine dehydrogenase domain then cleaves saccharopine to L-2-aminoadipate 6-semialdehyde (AASA) plus L-glutamate. AASA (in equilibrium with delta-1-piperideine-6-carboxylate, P6C) is oxidised to L-2-aminoadipate by the NAD-dependent aldehyde dehydrogenase ALDH7A1 (antiquitin); a block here causes accumulation of P6C, which inactivates pyridoxal-5'-phosphate and produces pyridoxine-dependent epilepsy. The PLP-dependent aminotransferase AADAT (KAT2) then transaminates 2-aminoadipate with 2-oxoglutarate to 2-oxoadipate (AADAT is also kynurenine aminotransferase II, linking to tryptophan metabolism). 2-oxoadipate is oxidatively decarboxylated to glutaryl-CoA by the 2-oxoadipate dehydrogenase DHTKD1 (with DLST and DLD), and glutaryl-CoA is dehydrogenated/decarboxylated to crotonyl-CoA by GCDH (glutaryl-CoA dehydrogenase), which continues to two acetyl-CoA. Inherited defects cause aminoadipic/oxoadipic aciduria (DHTKD1), pyridoxine-dependent epilepsy (ALDH7A1) and glutaric aciduria type 1 (GCDH).
All recommended fields populated.
✗ none found
No MODULE:lysine_catabolism_saccharopine deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
5 complete review(s) · 0 with deep research · 0 missing review · 5 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| AADAT Q8N5Z0 | ✓ | ✓ | ✗ |
| AASS Q9UDR5 | ✓ | ✓ | ✗ |
| ALDH7A1 P49419 | ✓ | ✓ | ✗ |
| DHTKD1 Q96HY7 | ✓ | ✓ | ✗ |
| GCDH Q92947 | ✓ | ✓ | ✗ |
L-lysine catabolism (GO:0019477) via the saccharopine pathway, grounded to the completed human gene reviews: AASS (Q9UDR5, bifunctional, GO:0047130 saccharopine dehydrogenase — on main), ALDH7A1 (P49419, GO:0004043 aminoadipate-semialdehyde dehydrogenase — curated here), AADAT (Q8N5Z0, GO:0047536 2-aminoadipate transaminase + GO:0016212 kynurenine transaminase + PLP — curated here), DHTKD1 (Q96HY7, GO:0160166 2-oxoadipate dehydrogenase — on main) and GCDH (Q92947, GO:0004361 glutaryl-CoA dehydrogenase — on main). AADAT and DHTKD1 also connect this pathway to the mitochondrial 2-oxodicarboxylate carrier SLC25A21 and to tryptophan/kynurenine metabolism. GO term ids/labels verified against the local go.db (note GO:0006554 "lysine catabolic process" is obsolete → GO:0019477 used). Downstream, crotonyl-CoA is metabolised to two acetyl-CoA. Disorders: ALDH7A1 — pyridoxine-dependent epilepsy; DHTKD1 — 2-aminoadipic/2-oxoadipic aciduria; GCDH — glutaric aciduria type 1 (macrocephaly, striatal injury, encephalopathic crises).
Bifunctional; converts L-lysine to 2-aminoadipate semialdehyde via saccharopine.
Oxidises AASA to L-2-aminoadipate.
Transaminates L-2-aminoadipate to 2-oxoadipate.
Oxidatively decarboxylates 2-oxoadipate to glutaryl-CoA.
Dehydrogenates/decarboxylates glutaryl-CoA to crotonyl-CoA.